1. Home
  2. CMND vs RELI Comparison

CMND vs RELI Comparison

Compare CMND & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMND
  • RELI
  • Stock Information
  • Founded
  • CMND 2017
  • RELI 2013
  • Country
  • CMND Canada
  • RELI United States
  • Employees
  • CMND N/A
  • RELI N/A
  • Industry
  • CMND Biotechnology: Pharmaceutical Preparations
  • RELI Specialty Insurers
  • Sector
  • CMND Health Care
  • RELI Finance
  • Exchange
  • CMND Nasdaq
  • RELI Nasdaq
  • Market Cap
  • CMND 5.3M
  • RELI 4.7M
  • IPO Year
  • CMND N/A
  • RELI N/A
  • Fundamental
  • Price
  • CMND $0.22
  • RELI $0.72
  • Analyst Decision
  • CMND
  • RELI
  • Analyst Count
  • CMND 0
  • RELI 0
  • Target Price
  • CMND N/A
  • RELI N/A
  • AVG Volume (30 Days)
  • CMND 23.9M
  • RELI 3.2M
  • Earning Date
  • CMND 09-11-2025
  • RELI 11-06-2025
  • Dividend Yield
  • CMND N/A
  • RELI 3.94%
  • EPS Growth
  • CMND N/A
  • RELI N/A
  • EPS
  • CMND N/A
  • RELI N/A
  • Revenue
  • CMND N/A
  • RELI $13,115,995.00
  • Revenue This Year
  • CMND N/A
  • RELI N/A
  • Revenue Next Year
  • CMND N/A
  • RELI N/A
  • P/E Ratio
  • CMND N/A
  • RELI N/A
  • Revenue Growth
  • CMND N/A
  • RELI N/A
  • 52 Week Low
  • CMND $0.20
  • RELI $0.67
  • 52 Week High
  • CMND $2.18
  • RELI $5.11
  • Technical
  • Relative Strength Index (RSI)
  • CMND 13.65
  • RELI 41.51
  • Support Level
  • CMND $0.24
  • RELI $0.67
  • Resistance Level
  • CMND $0.65
  • RELI $1.00
  • Average True Range (ATR)
  • CMND 0.11
  • RELI 0.06
  • MACD
  • CMND -0.06
  • RELI -0.02
  • Stochastic Oscillator
  • CMND 1.44
  • RELI 24.15

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

Share on Social Networks: